Everyone from rock stars to nonagenarians experiences hearing loss, but no drugs have ever been approved specifically to prevent or treat this problem. Recently, a handful of drug companies have started to make some noise, with a number of experimental compounds now in human trials. Elie Dolgin sounds off on what could be a multibillion dollar market.
This is a preview of subscription content, log in via an institution to check access.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Rauch, S.D. et al. J. Am. Med. Assoc. 305, 2071–2079 (2011).
Lin, F.R., Niparko, J.K. & Ferrucci, L. Arch. Intern. Med. 171, 1851–1852 (2011).
Suckfuell, M., Canis, M., Strieth, S., Scherer, H. & Haisch, A. Acta Otolaryngol. 127, 938–942 (2007).
Ewert, D.L. et al. Hear. Res. 285, 29–39 (2012).
Lynch, E. & Kil, J. Semin. Hear. 30, 47–55 (2009).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. Sound medicine. Nat Med 18, 642–644 (2012). https://doi.org/10.1038/nm0512-642
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0512-642
- Springer Nature America, Inc.